Results 231 to 240 of about 150,657 (357)

Integrative Modeling in the Age of Machine Learning: A Summary of HADDOCK Strategies in CAPRI Rounds 47–55

Proteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT The HADDOCK team participated in CAPRI rounds 47–55 as server, manual predictor, and scorers. Throughout these CAPRI rounds, we used a plethora of computational strategies to predict the structure of protein complexes. Of the 10 targets comprising 24 interfaces, we achieved acceptable or better models for 3 targets in the human category and 1 ...
Victor Reys, Marco Giulini, Vlad Cojocaru, Anna Engel, Xiaotong Xu, Jorge Roel‐Touris, Cunliang Geng, Francesco Ambrosetti, Brian Jiménez‐García, Zuzana Jandova, Panagiotis I. Koukos, Charlotte van Noort, João M. C. Teixeira, Siri C. van Keulen, Manon Réau, Rodrigo V. Honorato, Alexandre M. J. J. Bonvin   +16 more
wiley   +1 more source

Histocompatibility antigens (HLA) in acute lymphocytic leukemia

The Turkish Journal of Pediatrics, 1986
L Ulukutlu, H Yazici, H Cam, E Esen, F Ozbakir   +4 more
doaj  

MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigens. [PDF]

J Immunother Cancer
Jenkins JW, Peña A, Castro SA, Hansen MJ, Van Keulen VP, Foster ST, Rios-Cruz PE, Yakubov J, Hinson DT, Olivier SM, Pavelko KD, Felts SJ, Johnson AJ, Pease LR.   +13 more
europepmc   +1 more source

Organization of the AKR Qa region [PDF]

, 1989
Bevec, Dorian, Grosshaus, C., Messer, Gerald, Schmidt, Walter, Schwemmle, Sabine, Steinmetz, M., Weiss, Elisabeth H.   +6 more
core   +1 more source

Massive Sampling Strategy for Antibody–Antigen Targets in CAPRI Round 55 With MassiveFold

Proteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT Massive sampling with AlphaFold2 improves protein–protein complex predictions. This has been shown during the last CASP15‐CAPRI blind prediction round by the AFsample tool. However, more difficult targets including antibody–antigen binding remain challenging. CAPRI Round 55 consisted of three antibody–antigen targets and one heterotrimer.
Nessim Raouraoua, Marc F. Lensink, Guillaume Brysbaert   +2 more
wiley   +1 more source

Evaluation of the Frequency of HLA-DQ2/DQ8 Genes Among Patients with Celiac Disease and Those on a Gluten-Free Diet. [PDF]

Foods
Kowalski MK, Domżał-Magrowska D, Małecka-Wojciesko E.   +2 more
europepmc   +1 more source

HISTOCOMPATIBILITY ANTIGENS OF HUMAN PLASMA

, 1973
Richard H. Aster, Bonnie H. Miskovich, Glenn E. Rodey   +2 more
openalex   +1 more source

Expression of major histocompatibility complex class I antigens as a strategy for the potentiation of immune recognition of tumor cells. [PDF]

, 1986
Karo Tanaka, Hiroaki Hayashi, Chieko Hamada, George Khoury, Gregory D. Jay   +4 more
openalex   +1 more source

A Multiple‐Model‐Informed Drug‐Development Approach for Optimal Regimen Selection of an Oncolytic Virus in Combination With Pembrolizumab

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 3, Page 572-582, March 2025.
ABSTRACT The antitumor efficacy of an intratumoral injection of a genetically engineered oncolytic vaccinia virus carrying human IL‐7 and murine IL‐12 genes (hIL‐7/mIL‐12‐VV) was demonstrated in CT26.WT‐bearing mice. In the CT26.WT‐bearing mouse model, the efficacy of the combination of hIL‐7/mIL‐12‐VV plus the anti‐programmed cell death protein (PD)‐1
Akihiro Yamada, Mary P. Choules, Frances A. Brightman, Shigeru Takeshita, Shinsuke Nakao, Nobuaki Amino, Takeshi Nakayama, Masato Takeuchi, Kanji Komatsu, Fernando Ortega, Hitesh Mistry, David Orrell, Christophe Chassagnole, Peter L. Bonate   +13 more
wiley   +1 more source

Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens.

Blood
Fuchs KJ, van de Meent M, Honders MW, Khatri I, Kester MGD, Koster EAS, Koutsoumpli G, de Ru AH, van Bergen CAM, van Veelen PA, 't Hoen PAC, van Balen P, van den Akker EB, Veelken JH, Halkes CJM, Falkenburg JHF, Griffioen M.   +16 more
europepmc   +1 more source